Summary:
- Researchers have developed a targeted therapeutic approach that addresses gum disease by neutralizing harmful bacteria while preserving the beneficial oral microbiome.
- The treatment utilizes a precision-based strategy to disrupt the virulence of pathogens like *Porphyromonas gingivalis* rather than using broad-spectrum antibiotics that cause collateral damage to oral health.